![]() |
![]() ![]() |
![]() |
Buy Request | ![]() | Sell Offer | ![]() | Company | ![]() | Reviews | ![]() |
Expire | Country | Pic | Subject | Popularity |
never | ![]() | ![]() | Anti-CSF2RA (Mavrilimumab)-MC-MMAF ADC | 154 |
never | ![]() | ![]() | Anti-CSF2RA (Mavrilimumab)-SMCC-DM1 ADC | 154 |
never | ![]() | ![]() | Anti-CSF2 (Namilumab)-SPDB-DM4 ADC | 154 |
never | ![]() | ![]() | Anti-CSF2 (Namilumab)-SMCC-DM1 ADC | 154 |
never | ![]() | ![]() | Anti-CFD (Lampalizumab)-MC-Vc-PAB-SN38 ADC | 154 |
never | ![]() | ![]() | Anti-CFD (Lampalizumab)-MC-Vc-PAB-MMAE ADC | 154 |
never | ![]() | ![]() | Anti-CFD (Lampalizumab)-MC-MMAF ADC | 154 |
never | ![]() | ![]() | Anti-CFD (Lampalizumab)-SPDB-DM4 ADC | 154 |
never | ![]() | ![]() | Anti-CFD (Lampalizumab)-SMCC-DM1 ADC | 154 |
never | ![]() | ![]() | Anti-CEACAM5 (Altumomab)-MC-Vc-PAB-SN38 ADC | 154 |
Copyright © toextrade Inc. All rights reserved. Contact us |